Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients

Journal of the American College of Cardiology

Volumn 36, Issue 7, 2000, Pages 2212-2218

  Elliott, Perry M ^a   Poloniecki, Jan ^a   Dickie, Shaughan ^a   Sharma, Sanjay ^a   Monserrat, Lorenzo ^a   Varnava, Amanda ^a   Mahon, Niall G ^a   McKenna, William J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE; EXERCISE; FEMALE; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUDDEN DEATH; SURVIVAL TIME; SYNCOPE;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 0033667442     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01003-2     Document Type: Article

References (34)

1. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
2. Arrhythmia in hypertrophic cardiomyopathy. 1. Influence on prognosis
3. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
4. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
5. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy
6. Predictors of sudden cardiac death in hypertrophic cardiomyopathy
7. Prognostic value of systemic blood pressure response during exercise in a community based population with hypertrophic cardiomyopathy
8. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy
9. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies
10. Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families
11. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A two-dimensional echocardiographic study
12. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: A wide-angle, two-dimensional echocardiographic study of 125 patients
13. The natural and unnatural history of hypertrophic obstructive cardiomyopathy
14. Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy
15. Prognosis in hypertrophic cardiomyopathy
16. Hypertrophic cardiomyopathy: Is a left ventricular outflow tract gradient a major prognostic determinant?
17. Hypertrophic cardiomyopathy: An important cause of sudden death
18. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatients population
19. Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population
20. Natural history of hypertrophic cardiomyopathy: A population based study, 1976 through 1990
21. Hypertrophic cardiomyopathy: A common disease with a good prognosis - Five-year experience of a district general hospital
22. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population
23. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort
24. Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest
25. Survival following cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
26. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia
27. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: Assessment in an unselected non-referral based patient population
28. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia
29. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy
30. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients
31. Hypertrophic cardiomyopathy: Role of the implantable cardioveter defibrillator
32. The automatic implantable cardioverter-defibrillator in young patients
33. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy